AU4233685A

AU4233685A – Antacid composition
– Google Patents

AU4233685A – Antacid composition
– Google Patents
Antacid composition

Info

Publication number
AU4233685A

AU4233685A
AU42336/85A
AU4233685A
AU4233685A
AU 4233685 A
AU4233685 A
AU 4233685A
AU 42336/85 A
AU42336/85 A
AU 42336/85A
AU 4233685 A
AU4233685 A
AU 4233685A
AU 4233685 A
AU4233685 A
AU 4233685A
Authority
AU
Australia
Prior art keywords
antacid composition
antacid
composition
treatment
pharmaceutical composition
Prior art date
1984-04-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU42336/85A
Other versions

AU578690B2
(en

Inventor
John David Beuhler
Wayne Martin Grim
Joseph Raymond Luber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Rorer International Overseas Inc

Original Assignee
Rorer International Overseas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1984-04-19
Filing date
1985-04-11
Publication date
1985-11-15

1985-04-11
Application filed by Rorer International Overseas Inc
filed
Critical
Rorer International Overseas Inc

1985-11-15
Publication of AU4233685A
publication
Critical
patent/AU4233685A/en

1988-11-03
Application granted
granted
Critical

1988-11-03
Publication of AU578690B2
publication
Critical
patent/AU578690B2/en

2005-04-11
Anticipated expiration
legal-status
Critical

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0012—Galenical forms characterised by the site of application

A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K33/00—Medicinal preparations containing inorganic active ingredients

A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/70—Carbohydrates; Sugars; Derivatives thereof

A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K33/00—Medicinal preparations containing inorganic active ingredients

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides

A61K47/12—Carboxylic acids; Salts or anhydrides thereof

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0087—Galenical forms not covered by A61K9/02 – A61K9/7023

A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/10—Dispersions; Emulsions

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/20—Pills, tablets, discs, rods

A61K9/2004—Excipients; Inactive ingredients

A61K9/2013—Organic compounds, e.g. phospholipids, fats

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/20—Pills, tablets, discs, rods

A61K9/2004—Excipients; Inactive ingredients

A61K9/2013—Organic compounds, e.g. phospholipids, fats

A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/20—Pills, tablets, discs, rods

A61K9/2004—Excipients; Inactive ingredients

A61K9/2022—Organic macromolecular compounds

A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

A pharmaceutical composition including magnesium alginate and an antacid material useful in the treatment of reflux esophagitis.

AU42336/85A
1984-04-19
1985-04-11
Antacid composition

Expired

AU578690B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US60179684A

1984-04-19
1984-04-19

US601796

1984-04-19

Publications (2)

Publication Number
Publication Date

AU4233685A
true

AU4233685A
(en)

1985-11-15

AU578690B2

AU578690B2
(en)

1988-11-03

Family
ID=24408805
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU42336/85A
Expired

AU578690B2
(en)

1984-04-19
1985-04-11
Antacid composition

Country Status (11)

Country
Link

EP
(1)

EP0179858B1
(en)

JP
(1)

JPH0764737B2
(en)

KR
(1)

KR850007561A
(en)

CN
(1)

CN85104754A
(en)

AT
(1)

ATE77750T1
(en)

AU
(1)

AU578690B2
(en)

CA
(1)

CA1259916A
(en)

DE
(1)

DE3586281T2
(en)

ES
(1)

ES8706029A1
(en)

FR
(1)

FR2563108B1
(en)

WO
(1)

WO1985004806A1
(en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4744986A
(en)

*

1986-03-07
1988-05-17
Rorer Pharmaceutical Corporation
Process for the preparation of a viscosity-stable antacid composition

DE3612086A1
(en)

*

1986-04-10
1987-10-15
Bayer Ag

PRESERVED ANTACIDA PREPARATIONS

DK179687D0
(en)

*

1987-04-08
1987-04-08
Farma Food As

PREPARATION

US5169638A
(en)

*

1991-10-23
1992-12-08
E. R. Squibb & Sons, Inc.
Buoyant controlled release powder formulation

US5360793A
(en)

*

1993-05-24
1994-11-01
Sterling Winthrop Inc.
Rafting antacid formulation

GB9504599D0
(en)

*

1995-03-03
1995-04-26
Reckitt & Colmann Prod Ltd
Improvements in or relating to organic compositions

JP2001501224A
(en)

*

1996-10-04
2001-01-30
メルク エンド カンパニー インコーポレーテッド

Methods and compositions for preventing and treating heartburn

EP1842544A3
(en)

*

1997-04-30
2007-10-17
Reckitt Benckiser Healthcare (UK) Limited
Alginate compositions

AU2002356493A1
(en)

*

2001-11-19
2003-06-10
Nobel Ilac Sanayii Ve Ticaret A.S.
New pharmaceutical combinations prepared with alginates and biphosphonates in order to prevent gastroesophageal reflux during use of oral biphoshonates

WO2005018613A1
(en)

*

2003-08-26
2005-03-03
Mandapro Ag
Pellets for the oral application of pharmaceutical active substances

DE102006037298A1
(en)

2006-08-08
2008-02-14
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh

Pharmaceutical composition, in particular antacid

IT1406155B1
(en)

*

2011-02-22
2014-02-14
Rossi

COMPOSITIONS OF MAGNESIUM ALGINATE AND DERIVATIVES AS ADIUVANTS IN THE TREATMENT OF GASTRIC REFLUX

EP2806880B2
(en)

2012-01-27
2020-04-22
Institute of Bioorganic Chemistry
Pharmaceutical composition as a substance for antireflux antacid drug

CN104688765A
(en)

*

2013-12-04
2015-06-10
博晖(大连)实业有限公司
Composition stomach medicine made from alginates

IT202100000059A1
(en)

*

2021-01-04
2022-07-04
Nyuma Pharma Srl

NEW COMPOSITIONS OF SUCRALFATE IN ALGINATE AND THEIR USE IN THERAPY

Family Cites Families (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

GB1363399A
(en)

*

1972-04-13
1974-08-14
Rotta Research Lab
Method of preparing an antacid pharmaceutical product

GB1524740A
(en)

*

1976-11-09
1978-09-13
Reckitt & Colmann Prod Ltd
Pharmaceutical compositions for use in the suppression of gastric reflux

GB1598375A
(en)

*

1978-02-17
1981-09-16
Anphar Sa
Aluminium magnesium carbonate

1985

1985-04-11
JP
JP60501870A
patent/JPH0764737B2/en
not_active
Expired – Lifetime

1985-04-11
AT
AT85902269T
patent/ATE77750T1/en
not_active
IP Right Cessation

1985-04-11
AU
AU42336/85A
patent/AU578690B2/en
not_active
Expired

1985-04-11
WO
PCT/US1985/000652
patent/WO1985004806A1/en
active
IP Right Grant

1985-04-11
EP
EP85902269A
patent/EP0179858B1/en
not_active
Expired – Lifetime

1985-04-11
DE
DE8585902269T
patent/DE3586281T2/en
not_active
Expired – Lifetime

1985-04-12
FR
FR8505556A
patent/FR2563108B1/en
not_active
Expired

1985-04-12
CA
CA000479059A
patent/CA1259916A/en
not_active
Expired

1985-04-18
KR
KR1019850002662A
patent/KR850007561A/en
not_active
Application Discontinuation

1985-04-19
ES
ES542430A
patent/ES8706029A1/en
not_active
Expired

1985-06-12
CN
CN198585104754A
patent/CN85104754A/en
active
Pending

Also Published As

Publication number
Publication date

CA1259916A
(en)

1989-09-26

ES542430A0
(en)

1987-06-01

ATE77750T1
(en)

1992-07-15

JPH0764737B2
(en)

1995-07-12

FR2563108B1
(en)

1987-09-04

ES8706029A1
(en)

1987-06-01

KR850007561A
(en)

1985-12-07

EP0179858B1
(en)

1992-07-01

DE3586281T2
(en)

1992-12-10

JPS61501916A
(en)

1986-09-04

EP0179858A4
(en)

1986-09-15

EP0179858A1
(en)

1986-05-07

CN85104754A
(en)

1986-12-10

AU578690B2
(en)

1988-11-03

FR2563108A1
(en)

1985-10-25

WO1985004806A1
(en)

1985-11-07

DE3586281D1
(en)

1992-08-06

Similar Documents

Publication
Publication Date
Title

AU572684B2
(en)

1988-05-12

Tipping or tipping and lifting apparatus

HK1000667A1
(en)

1998-04-17

Diene block polymer and polymer composition

AU609815B2
(en)

1991-05-09

Improved superabsorbent composition and process

EP0287817A3
(en)

1989-08-30

Photopolymerisable composition and registration material prepared therewith

EP0284938A3
(en)

1989-08-30

Photopolymerisable composition and registration material prepared therewith

AU3821689A
(en)

1990-02-01

Enzyme electrodes and improvements in the manufacture thereof

AU1126688A
(en)

1988-08-11

Cholestyramine composition and process for its preparation

AU4233685A
(en)

1985-11-15

Antacid composition

AU2614888A
(en)

1989-05-02

Soluble human cd4 fragments and uses therefor

AU1114388A
(en)

1988-08-04

Anesthetic composition and method of using the same

EP0304802A3
(en)

1990-03-28

Pharmaceutical composition and the use thereof

AU8294387A
(en)

1988-08-11

Lubricant composition and process

AU8316587A
(en)

1988-07-07

Pharmaceutical compositions and their use

AU4426289A
(en)

1990-05-01

Methods for interfering with hiv multiplication and composition for the treatment of aids

AU7580187A
(en)

1988-01-12

Androstane-type and cortical aminoesters

ZA897692B
(en)

1990-06-27

Triglycerides,composition comprising such triglycerides,and use of such composition

AU3502789A
(en)

1989-11-23

Composition and use

AU1279188A
(en)

1988-09-08

Cement composition and use thereof

NZ223293A
(en)

1990-02-26

Beta-alkyl melatonins and pharmaceutical compositions

AU1279788A
(en)

1988-09-08

Compounds and treatment

AU2463988A
(en)

1989-05-04

An improved method and composition

AU1789788A
(en)

1989-01-04

Cyclopolyglycuronic acid composition and its use

AU2051788A
(en)

1989-04-27

An improved method and pharmaceutical composition

JPS6466146A
(en)

1989-03-13

Fluorobenzyl ester, manufacture and insecticidal composition

AU1797088A
(en)

1989-01-04

An anti-leukotriene composition and its uses

Download PDF in English

None